46 related articles for article (PubMed ID: 11283929)
1. The associations between statin use and prostate cancer screening, prostate size, high-grade prostatic intraepithelial neoplasia (PIN), and prostate cancer.
Fowke JH; Motley SS; Barocas DA; Cookson MS; Concepcion R; Byerly S; Smith JA
Cancer Causes Control; 2011 Mar; 22(3):417-26. PubMed ID: 21170754
[TBL] [Abstract][Full Text] [Related]
2. Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917.
Marshall JR; Tangen CM; Sakr WA; Wood DP; Berry DL; Klein EA; Lippman SM; Parnes HL; Alberts DS; Jarrard DF; Lee WR; Gaziano JM; Crawford ED; Ely B; Ray M; Davis W; Minasian LM; Thompson IM
Cancer Prev Res (Phila); 2011 Nov; 4(11):1761-9. PubMed ID: 21896650
[TBL] [Abstract][Full Text] [Related]
3. Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?
Hudson MA; Luo S; Chrusciel T; Yan Y; Grubb RL; Carson K; Scherrer JF
Urol Oncol; 2014 Jan; 32(1):34.e9-18. PubMed ID: 23506962
[TBL] [Abstract][Full Text] [Related]
4. Promoter methylation of MCAM, ERα and ERβ in serum of early stage prostate cancer patients.
Brait M; Banerjee M; Maldonado L; Ooki A; Loyo M; Guida E; Izumchenko E; Mangold L; Humphreys E; Rosenbaum E; Partin A; Sidransky D; Hoque MO
Oncotarget; 2017 Feb; 8(9):15431-15440. PubMed ID: 28147335
[TBL] [Abstract][Full Text] [Related]
5. Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention.
Kumar NB; Pow-Sang J; Egan KM; Spiess PE; Dickinson S; Salup R; Helal M; McLarty J; Williams CR; Schreiber F; Parnes HL; Sebti S; Kazi A; Kang L; Quinn G; Smith T; Yue B; Diaz K; Chornokur G; Crocker T; Schell MJ
Cancer Prev Res (Phila); 2015 Oct; 8(10):879-87. PubMed ID: 25873370
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of screen detected prostate cancer in West Africans: implications for racial disparity of prostate cancer.
Hsing AW; Yeboah E; Biritwum R; Tettey Y; De Marzo AM; Adjei A; Netto GJ; Yu K; Li Y; Chokkalingam AP; Chu LW; Chia D; Partin A; Thompson IM; Quraishi SM; Niwa S; Tarone R; Hoover RN
J Urol; 2014 Sep; 192(3):730-5. PubMed ID: 24747091
[TBL] [Abstract][Full Text] [Related]
7. On the Black-White Disparity in Prostate Cancer Mortality.
Brawley OW; Fletcher SA
JNCI Cancer Spectr; 2022 Feb; 6(1):. PubMed ID: 35047753
[No Abstract] [Full Text] [Related]
8. Race Differences in Telomere Length in Benign Prostate Biopsies and Subsequent Risk of Prostate Cancer.
Rybicki BA; Sadasivan SM; Chen Y; Loveless I; Gupta NS; Chitale DA; Williamson SR; Rundle AG; Tang DL
Cancer Epidemiol Biomarkers Prev; 2022 May; 31(5):991-998. PubMed ID: 35247880
[TBL] [Abstract][Full Text] [Related]
9. Importance of Estrogenic Signaling and Its Mediated Receptors in Prostate Cancer.
Lau KM; To KF
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589731
[TBL] [Abstract][Full Text] [Related]
10. Safety and tolerability of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN).
Paltsev M; Kiselev V; Muyzhnek E; Drukh V; Kuznetsov I; Pchelintseva O
EPMA J; 2014; 5(1):18. PubMed ID: 25309637
[TBL] [Abstract][Full Text] [Related]
11. Molecular Targeted Therapies Using Botanicals for Prostate Cancer Chemoprevention.
Kumar N; Chornokur G
Transl Med (Sunnyvale); 2012 Dec; Suppl 2():005. PubMed ID: 24527269
[TBL] [Abstract][Full Text] [Related]
12. High grade prostate intraepithelial neoplasia (PIN) is a PSA-independent risk factor for prostate cancer in African American men: results from a pilot study.
Chornokur G; Han G; Tanner R; Lin HY; Green BL; Pow-Sang J; Phelan CM
Cancer Lett; 2013 May; 331(2):154-7. PubMed ID: 23268329
[TBL] [Abstract][Full Text] [Related]
13. Precursor lesions to prostatic adenocarcinoma.
Epstein JI
Virchows Arch; 2009 Jan; 454(1):1-16. PubMed ID: 19048290
[TBL] [Abstract][Full Text] [Related]
14. Prostatic intraepithelial neoplasia: an overview.
Brawer MK
Rev Urol; 2005; 7 Suppl 3(Suppl 3):S11-8. PubMed ID: 16985875
[TBL] [Abstract][Full Text] [Related]
15. High-grade prostatic intraepithelial neoplasia.
Bostwick DG; Liu L; Brawer MK; Qian J
Rev Urol; 2004; 6(4):171-9. PubMed ID: 16985598
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of correlations between biopsy-detected high grade prostatic intraepithelial neoplasia, serum prostate specific antigen concentration, and race.
Fowler JE; Bigler SA; Lynch C; Wilson SS; Farabaugh PB
Cancer; 2001 Apr; 91(7):1291-6. PubMed ID: 11283929
[TBL] [Abstract][Full Text] [Related]
17. Race is not a predictor of prostate cancer detection on repeat prostate biopsy.
Carver BS; Bozeman CB; Simoneaux WJ; Venable DD; Kattan MW; Eastham JA
J Urol; 2004 Nov; 172(5 Pt 1):1853-5. PubMed ID: 15540737
[TBL] [Abstract][Full Text] [Related]
18. High grade intraepithelial neoplasia of prostate is associated with values of prostate specific antigen related parameters intermediate between prostate cancer and normal levels.
Obralic N; Kulovac B
Bosn J Basic Med Sci; 2011 Nov; 11(4):223-7. PubMed ID: 22117828
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of cancer detection in black and white men with normal digital rectal examination but prostate specific antigen equal or greater than 4.0 ng/mL.
Fowler JE; Bigler SA; Farabaugh PB
Cancer; 2002 Mar; 94(6):1661-7. PubMed ID: 11920526
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
